Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T17:06:33.713Z.
Calculation as of: 2026-10-06T17:06:33.713Z.
Quote observation: 2026-10-06T17:05:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0892caefd8f82b9b6348fc9a5fa5a469bdb14ad1115ffcc50d65bebd568510ae
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-08-12.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
34.14x
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Journey Medical Corporation
Market Cap
$175.86M
EV/FCF Ratio
N/A
TTM Avg
34.14x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.00M
EV/FCF Ratio
N/A
TTM Avg
3.88x
3Y Avg
3.88x
5Y Avg
3.88x
Market Cap
$172.23M
EV/FCF Ratio
N/A
TTM Avg
277.79x
3Y Avg
277.79x
5Y Avg
277.79x
Market Cap
$171.07M
EV/FCF Ratio
9.21x
TTM Avg
14.67x
3Y Avg
65.56x
5Y Avg
51.74x
Market Cap
$181.71M
EV/FCF Ratio
N/A
TTM Avg
28.20x
3Y Avg
28.15x
5Y Avg
28.15x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Journey Medical Corporation (DERM) | $175.86M | N/A | 34.14x | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.31M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $178.36M | N/A | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.00M | N/A | 3.88x | 3.88x | 3.88x |
| Cue Biopharma, Inc. (CUE)vs › | $172.38M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $172.23M | N/A | 277.79x | 277.79x | 277.79x |
| Organogenesis Holdings Inc. (ORGO)vs › | $171.07M | 9.21x | 14.67x | 65.56x | 51.74x |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.71M | N/A | 28.20x | 28.15x | 28.15x |
| MediWound Ltd. (MDWD)vs › | $169.76M | N/A | 6.83x | 6.83x | 6.83x |
| Nkarta, Inc. (NKTX)vs › | $169.20M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2024-08-12 | 65.49x |
| 2024-08-09 | 78.25x |
| 2024-08-08 | 77.92x |
| 2024-08-07 | 77.25x |
| 2024-08-06 | 78.25x |
| 2024-08-05 | 76.41x |
| 2024-08-02 | 82.45x |
| 2024-08-01 | 87.48x |
| 2024-07-31 | 87.82x |
| 2024-07-30 | 86.98x |
| 2024-07-29 | 87.82x |
| 2024-07-26 | 86.31x |
| 2024-07-25 | 84.13x |
| 2024-07-24 | 85.30x |
| 2024-07-23 | 85.47x |
| 2024-07-22 | 86.48x |
| 2024-07-19 | 86.31x |
| 2024-07-18 | 87.15x |
| 2024-07-17 | 90.84x |
| 2024-07-16 | 93.86x |
| 2024-07-15 | 92.35x |
| 2024-07-12 | 89.67x |
| 2024-07-11 | 90.00x |
| 2024-07-10 | 87.15x |
| 2024-07-09 | 88.83x |
| 2024-07-08 | 90.17x |
| 2024-07-05 | 82.11x |
| 2024-07-03 | 81.11x |
| 2024-07-02 | 82.62x |
| 2024-07-01 | 84.80x |
| 2024-06-28 | 89.33x |
| 2024-06-27 | 80.94x |
| 2024-06-26 | 80.94x |
| 2024-06-25 | 78.25x |
| 2024-06-24 | 77.41x |
| 2024-06-21 | 81.61x |
| 2024-06-20 | 86.48x |
| 2024-06-18 | 84.97x |
| 2024-06-17 | 88.16x |
| 2024-06-14 | 88.16x |
| 2024-06-13 | 84.80x |
| 2024-06-12 | 94.37x |
| 2024-06-11 | 90.00x |
| 2024-06-10 | 88.83x |
| 2024-06-07 | 73.55x |
| 2024-06-06 | 73.22x |
| 2024-06-05 | 69.36x |
| 2024-06-04 | 67.17x |
| 2024-06-03 | 61.97x |
| 2024-05-31 | 60.12x |
| 2024-05-30 | 58.44x |
| 2024-05-29 | 59.28x |
| 2024-05-28 | 55.09x |
| 2024-05-24 | 55.09x |
| 2024-05-23 | 55.09x |
| 2024-05-22 | 54.25x |
| 2024-05-21 | 51.23x |
| 2024-05-20 | 51.73x |
| 2024-05-17 | 52.57x |
| 2024-05-16 | 55.42x |
| 2024-05-15 | 54.92x |
| 2024-05-14 | 250.21x |
| 2024-05-13 | 246.99x |
| 2024-05-10 | 242.16x |
| 2024-05-09 | 243.77x |
| 2024-05-08 | 246.99x |
| 2024-05-07 | 236.52x |
| 2024-05-06 | 245.38x |
| 2024-05-03 | 256.65x |
| 2024-05-02 | 251.82x |
| 2024-05-01 | 242.16x |
| 2024-04-30 | 256.65x |
| 2024-04-29 | 227.67x |
| 2024-04-26 | 233.30x |
| 2024-04-25 | 241.35x |
| 2024-04-24 | 233.30x |
| 2024-04-23 | 244.57x |
| 2024-04-22 | 244.57x |
| 2024-04-19 | 239.74x |
| 2024-04-18 | 247.79x |
| 2024-04-17 | 270.34x |
| 2024-04-16 | 265.51x |
| 2024-04-15 | 283.22x |
| 2024-04-12 | 315.43x |
| 2024-04-11 | 306.57x |
| 2024-04-10 | 312.21x |
| 2024-04-09 | 281.61x |
| 2024-04-08 | 290.47x |
| 2024-04-05 | 255.85x |
| 2024-04-04 | 310.60x |
| 2024-04-03 | 234.91x |
| 2024-04-02 | 233.30x |
| 2024-04-01 | 226.06x |
| 2024-03-28 | 4.32x |
| 2024-03-27 | 4.66x |
| 2024-03-26 | 4.33x |
| 2024-03-25 | 3.08x |
| 2024-03-22 | 3.70x |
| 2024-03-21 | 4.54x |
| 2024-03-20 | 4.58x |
| 2024-03-19 | 4.50x |
| 2024-03-18 | 4.41x |
| 2024-03-15 | 3.86x |
| 2024-03-14 | 3.97x |
| 2024-03-13 | 3.88x |
| 2024-03-12 | 3.99x |
| 2024-03-11 | 3.81x |
| 2024-03-08 | 3.94x |
| 2024-03-07 | 3.97x |
| 2024-03-06 | 4.01x |
| 2024-03-05 | 4.40x |
| 2024-03-04 | 4.84x |
| 2024-03-01 | 5.05x |
| 2024-02-29 | 4.76x |
| 2024-02-28 | 4.27x |
| 2024-02-27 | 4.94x |
| 2024-02-26 | 4.46x |
| 2024-02-23 | 4.27x |
| 2024-02-22 | 4.43x |
| 2024-02-21 | 4.45x |
| 2024-02-20 | 4.40x |
| 2024-02-16 | 5.26x |
| 2024-02-15 | 5.49x |
| 2024-02-14 | 5.59x |
| 2024-02-13 | 5.65x |
| 2024-02-12 | 6.38x |
| 2024-02-09 | 6.42x |
| 2024-02-08 | 6.06x |
| 2024-02-07 | 5.77x |
| 2024-02-06 | 5.44x |
| 2024-02-05 | 5.77x |
| 2024-02-02 | 6.17x |
| 2024-02-01 | 5.67x |
| 2024-01-31 | 6.22x |
| 2024-01-30 | 6.24x |
| 2024-01-29 | 6.63x |
| 2024-01-26 | 6.53x |
| 2024-01-25 | 6.84x |
| 2024-01-24 | 6.94x |
| 2024-01-23 | 7.23x |
| 2024-01-22 | 7.07x |
| 2024-01-19 | 6.58x |
| 2024-01-18 | 6.43x |
| 2024-01-17 | 6.64x |
| 2024-01-16 | 6.84x |
| 2024-01-12 | 6.17x |
| 2024-01-11 | 6.42x |
| 2024-01-10 | 7.12x |
| 2024-01-09 | 7.07x |
| 2024-01-08 | 7.05x |
| 2024-01-05 | 6.55x |
| 2024-01-04 | 6.42x |
| 2024-01-03 | 6.43x |
| 2024-01-02 | 7.17x |
| 2023-12-29 | 7.70x |
| 2023-12-28 | 8.68x |
| 2023-12-27 | 9.79x |
| 2023-12-26 | 9.64x |
| 2023-12-22 | 11.28x |
| 2023-12-21 | 11.17x |
| 2023-12-20 | 10.60x |
| 2023-12-19 | 10.73x |
| 2023-12-18 | 10.60x |
| 2023-12-15 | 9.28x |
| 2023-12-14 | 8.42x |
| 2023-12-13 | 8.89x |
| 2023-12-12 | 8.58x |
| 2023-12-11 | 8.22x |
| 2023-12-08 | 7.80x |
| 2023-12-07 | 9.20x |
| 2023-12-06 | 8.24x |
| 2023-12-05 | 7.67x |
| 2023-12-04 | 6.42x |
| 2023-12-01 | 5.49x |
| 2023-11-30 | 5.28x |
| 2023-11-29 | 4.92x |
| 2023-11-28 | 7.12x |
| 2023-11-27 | 6.45x |
| 2023-11-24 | 5.41x |
| 2023-11-22 | 5.29x |
| 2023-11-21 | 5.34x |
| 2023-11-20 | 5.11x |
| 2023-11-17 | 4.82x |
| 2023-11-16 | 4.87x |
| 2023-11-15 | 4.94x |
| 2023-11-14 | 4.87x |
| 2023-11-13 | 4.79x |
| 2023-11-10 | 4.40x |
| 2022-03-28 | 10.62x |
| 2022-03-25 | 10.41x |
| 2022-03-24 | 10.57x |
| 2022-03-23 | 10.43x |
| 2022-03-22 | 10.20x |
| 2022-03-21 | 10.13x |
| 2022-03-18 | 9.43x |
| 2022-03-17 | 10.32x |
| 2022-03-16 | 10.40x |
| 2022-03-15 | 9.82x |
| 2022-03-14 | 9.67x |
| 2022-03-11 | 10.20x |
| 2022-03-10 | 10.40x |
| 2022-03-09 | 10.48x |
| 2022-03-08 | 10.80x |
| 2022-03-07 | 10.79x |
| 2022-03-04 | 10.35x |
| 2022-03-03 | 10.93x |
| 2022-03-02 | 11.12x |
| 2022-03-01 | 10.99x |
| 2022-02-28 | 11.26x |
| 2022-02-25 | 11.55x |
| 2022-02-24 | 11.21x |
| 2022-02-23 | 11.68x |
| 2022-02-22 | 11.41x |
| 2022-02-18 | 11.74x |
| 2022-02-17 | 11.86x |
| 2022-02-16 | 11.75x |
| 2022-02-15 | 11.54x |
| 2022-02-14 | 11.44x |
| 2022-02-11 | 11.46x |
| 2022-02-10 | 11.47x |
| 2022-02-09 | 11.29x |
| 2022-02-08 | 11.26x |
| 2022-02-07 | 11.60x |
| 2022-02-04 | 11.94x |
| 2022-02-03 | 11.97x |
| 2022-02-02 | 12.28x |
| 2022-02-01 | 12.02x |
| 2022-01-31 | 11.63x |
| 2022-01-28 | 11.38x |
| 2022-01-27 | 11.16x |
| 2022-01-26 | 11.26x |
| 2022-01-25 | 11.35x |
| 2022-01-24 | 11.21x |
| 2022-01-21 | 11.13x |
| 2022-01-20 | 11.24x |
| 2022-01-19 | 11.52x |
| 2022-01-18 | 11.16x |
| 2022-01-14 | 11.27x |
| 2022-01-13 | 11.38x |
| 2022-01-12 | 11.71x |
| 2022-01-11 | 11.88x |
| 2022-01-10 | 11.13x |
| 2022-01-07 | 11.15x |
| 2022-01-06 | 10.59x |
| 2022-01-05 | 10.94x |
| 2022-01-04 | 11.47x |
| 2022-01-03 | 11.59x |
| 2021-12-31 | 11.69x |
| 2021-12-30 | 11.37x |
| 2021-12-29 | 11.74x |
| 2021-12-28 | 11.72x |
| 2021-12-27 | 12.19x |
| 2021-12-23 | 12.19x |
| 2021-12-22 | 12.66x |
| 2021-12-21 | 13.81x |
| 2021-12-20 | 13.83x |
| 2021-12-17 | 14.19x |
| 2021-12-16 | 14.39x |
